Dr. Reddy’s completes USFDA audit for Srikakulam API manufacturing facility

15 Apr 2017 Evaluate

Dr. Reddy’s Laboratories’ API manufacturing plant at Srikakulam (SEZ) in state of Andhra Pradesh has completed the audit by the US Food and Drug Administration (USFDA) on April 14, 2017 with no observations.

Besides, the company is recalling 1,728 bottles of Rivastigmine Tartrate capsules, used for treatment of dementia, due to cross-contamination with other products from the US market. The company’s US arm, Dr. Reddy’s Laboratories Inc is recalling Rivastigmine Tartrate capsules 1.5 mg in 60-count bottle manufactured by the company in India.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1250.00 -21.05 (-1.66%)
01-Jan-2026 13:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.10
Dr. Reddys Lab 1250.00
Cipla 1499.50
Zydus Lifesciences 913.15
Lupin 2100.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×